Skip to content

Effect Of PRF Versus Xenograft In Closed Sinus Lift.

Prf Controlled, Randamized Clinical Trial of THE EFFECT OF PLATELET RICH FIBRIN( PRF ) VERSUS XENOGRAFT IN CLOSED SINUS LIFT AND IMLANT PLACEMENT ON IMPLANT STABILITY IN PATIENTS WITH MISSING MAXILLARY PREMOLAR.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03684954
Enrollment
10
Registered
2018-09-26
Start date
2018-10-01
Completion date
2019-08-30
Last updated
2018-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implant or Graft; Rejection

Brief summary

Indirect sinus lift with used PRF as a graft material versus xenograft

Detailed description

Crestal incision and reflect the tissue until exposure of the bone, then use drilling to make osteotomy. Then use sutable osteotomes to elevate the sinus floor, then pack of Prf or bone graft in the osteotomy and implant placement . Then closed the flap and suturing.

Interventions

OTHERPrf

Take 10 cc blood from patient and gain prf

Sponsors

Mahmoud adel shaaban
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Single investigator

Intervention model description

Patallel Assignment

Eligibility

Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Edentulous area and bone high at least 5-6 mm below the maxillary sinus at maxillary premolar. * Good oral hygiene.

Exclusion criteria

* bad oral hygiene. * patient with systemic disease that may affect normal healing * pregnant patients. * patients with bone diseases and presence of periapical pathology affecting the neighboring teeth. * Heavy smoker more than 20 cigarettes per day

Design outcomes

Primary

MeasureTime frameDescription
Primary stability by ostell deviceup to 3 monthsImplant stability will be mesured by ostell device, implant stability will be mesured intra operative at 0 ( time of implant placement ) and 2, 4, 6, 10 and 12 weeks after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026